emetine has been researched along with Carcinoma, Mucoepidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borgato, GB; Castilho, RM; de Castro Júnior, G; Kowalski, LP; Lopes, MA; Martins, MD; Nor, JE; Rocha, GZ; Santos-Silva, AR; Silva, LC; Squarize, CH; Vargas, PA; Wagner, VP | 1 |
| Almeida, LO; Castilho, RM; Martins, MAT; Martins, MD; Nör, JE; Squarize, CH; Wagner, VP; Warner, KA | 1 |
2 other study(ies) available for emetine and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells.
Topics: Acetylation; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Emetine; Histones; Humans; Neoplastic Stem Cells | 2022 |
Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.
Topics: Antineoplastic Agents; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Emetine; Histone Deacetylase Inhibitors; Humans; Neoplastic Stem Cells; NF-kappa B; Protein Synthesis Inhibitors; Salivary Gland Neoplasms; Vorinostat | 2018 |